SHP Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

SHP Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.67K	Buy	+100	New	+$8.75K	﹤0.01%	940

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

SHP Wealth Management's IHE Position: Q1 2026 in Review

SHP Wealth Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q1 2026: 100 shares worth $8.67K. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings.

194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

SHP Wealth Management held 100 shares of iShares US Pharmaceuticals ETF worth $8.67K as of Q1 2026.
iShares US Pharmaceuticals ETF was a new SHP Wealth Management position in Q1 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #940 holding.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.